FDA approves Colgate product name change
This article was originally published in The Tan Sheet
Executive Summary
FDA approves Colgate-Palmolive's Feb. 19 supplemental new drug application to change the name of its Colgate Total Fresh Stripe Gel Toothpaste to Colgate Total Enamel Strength Stripe Toothpaste, the agency says. FDA says the firm must use final printed labeling identical to what it submitted and requires Colgate submit the final label to the agency no more than 30 days after printing
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.